查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1470633

吸入器和霧化器市場：按產品、適應症、分銷型態分類 - 2024-2030 年全球預測

Inhalers & Nebulizers Market by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Mode - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年吸入器和霧化器市場規模為93億美元，預計2024年將達到114.5億美元，2030年將達到386.3億美元，複合年成長率為22.55%。

吸入器是一種緊湊的攜帶式醫療設備，可將藥物直接輸送到肺部。吸入器有多種形式；定量吸入器 (MDI) 以氣霧劑的型態釋放固定型態的藥物，而乾粉吸入器 (DPI) 以患者吐出的乾粉型態輸送藥物。霧化器是一種電子設備，可將液體藥物變成細霧，患者可以透過面罩或吸嘴吸入。患有呼吸道疾病的患者主要使用吸入器和霧化器來給藥。由於污染和吸煙習慣導致呼吸系統疾病的發病率不斷增加，以及人們對呼吸系統疾病早期診斷和治療必要性的認知不斷增強，對吸入器和霧化器的需求不斷增加。然而，先進吸入器技術的高成本、藥物依從性的複雜性以及患者正確使用吸入器設備時的錯誤限制了吸入器和霧化器的普及。也就是說，與數位功能整合的智慧吸入器的開拓，以監控使用模式和提高合規性，以及可自訂選項的出現，以改善用戶體驗，正在推動吸入器和霧化器市場的範圍在全球範圍內擴大。

主要市場統計
基準年[2023] 93億美元
預測年份 [2024] 114.5億美元
預測年份 [2030] 386.3億美元
複合年成長率（%） 22.55%

產品 廣泛使用吸入器來克服呼吸道疾病的負擔

吸入器是一種手持式設備，可將藥物以霧狀或粉末狀直接輸送到肺部。乾粉吸入器 (DPI) 以乾燥的細粉形式輸送藥物。患者透過吹嘴深深地吸氣到肺部。 DPI 通常用於長期維持治療，由於其易於使用和攜帶而受到一些患者的青睞。定量吸入器是常用的吸入器，其含有懸浮在加壓罐內的推進劑中的藥物。當您按下藥罐時，一定量的藥物會以氣霧劑的形式釋放，並被吸入肺部。霧化器是醫療設備，用於以霧狀將藥物吸入肺部。與同時輸送單一劑量的吸入器不同，霧化器可以在幾分鐘內連續輸送藥物。噴射霧化器或壓縮機霧化器使用壓縮空氣將液體藥物變成細霧。噴射霧化器通常用於臨床和家庭環境，但由於其尺寸和需要空氣壓縮機，它們的噪音相對較大且不太攜帶。網狀霧化器是一種新型霧化器，使用細網產生藥霧。篩孔式噴霧器採用電池供電且方攜帶帶，非常適合外食或需要外服藥的患者。超音波霧化器利用高頻聲波產生振動，將藥物變成細霧。超音波霧化器並不適合所有藥物，因為超音波產生的熱量會劣化某些化合物。

展示：消費者越來越偏好吸入器和霧化器來治療氣喘

氣喘是一種慢性肺部疾病，因氣道狹窄而導致呼吸急促、喘息、胸悶和咳嗽。氣喘患者選擇吸入器和霧化器通常取決於年齡、氣喘嚴重程度、易用性和患者偏好等因素。慢性阻塞性肺病會導致氣流阻塞和呼吸相關問題。治療通常涉及長效支氣管擴張劑、吸入性皮質類固醇和其他控制症狀的藥物。氣喘治療傾向於使用更廣泛的短效藥物來進行急性管理和症狀控制。另一方面，慢性阻塞性肺病的治療更著重於長效藥物來控制慢性症狀。

區域洞察

由於呼吸系統疾病的高發生率、政府的核准以及新穎產品系列的開發，美洲是一個高度新興和標準化的市場。美洲客戶的購買行為受到技術進步和投資創新輸送系統的大型製藥供應商的強烈影響。在亞太地區，對醫療保健基礎設施和當地藥品製造的投資正在推動吸入器和霧化器市場的成長。龐大的人口、不斷增加的呼吸系統疾病發病率以及學名藥的使用趨勢正在擴大亞太地區吸入器和霧化器市場的範圍。歐洲市場複雜、監管嚴格，先進吸入器設備的普及很高。對患者依從性和易用性的關注正在推動全部區域對智慧連網型吸入器的需求。非洲是一個呼吸系統疾病負擔較高的新興市場，但獲得醫療設施的機會有限。全部區域的高淨值客戶群見證了醫療保健支出的增加以及對優質醫療保健服務和產品的渴望。

FPNV定位矩陣

FPNV定位矩陣對於評估吸入器和霧化器市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對吸入器和霧化器市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.吸入器/霧化器市場的市場規模和預測是多少？

2.吸入器和霧化器市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3.吸入器/霧化器市場的技術趨勢和法規結構是什麼？

4.吸入器/霧化器市場主要供應商的市場佔有率是多少？

5.進入吸入器/霧化器市場的適當型態和策略性手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球呼吸系統疾病發生率上升
      • 霧化器和數位化產品的採用增加
      • 智慧吸入器製造商與軟體公司之間的數位健康合作夥伴關係
    • 抑制因素
      • 智慧吸入器開發的可用性有限且高成本
    • 機會
      • 智慧吸入器設備和系統的技術進步
      • 市場參與企業增加投資和研發
    • 任務
      • 與吸入器和霧化器相關的實際問題
  • 市場區隔分析
    • 產品：廣泛使用吸入器以克服呼吸系統疾病的負擔
    • 適應症：消費者對氣喘治療中吸入器和霧化器的偏好不斷增加
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化
    • 專利分析及趨勢

第6章吸入器/霧化器市場：依產品

  • 吸入器
  • 噴霧器

第7章依適應症分類的吸入器/霧化器市場

  • 氣喘
  • 慢性阻塞性肺病

第8章依輸送模式分類的吸入器和霧化器市場

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章美洲吸入器和霧化器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太吸入器和霧化器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲吸入器/霧化器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 1nhaler 融資 250 萬美元開發永續吸入器
    • 羽扇豆科在德國為氣喘患者推出吸入器
    • 協同效應 Life Sciences推出可攜式霧化器“Nebi”

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-434CCDA05167

[192 Pages Report] The Inhalers & Nebulizers Market size was estimated at USD 9.30 billion in 2023 and expected to reach USD 11.45 billion in 2024, at a CAGR 22.55% to reach USD 38.63 billion by 2030.

Inhalers are compact, portable medical devices that deliver medication directly into the lungs. Inhalers come in various forms, including metered-dose inhalers (MDIs), which release a specific amount of medication in aerosol form, and dry powder inhalers (DPIs), which dispense medication in a dry powder form triggered by the patient's inhalation. Nebulizers are electronic devices that transform liquid medication into a fine mist, allowing patients to inhale the substance through a face mask or mouthpiece. Patients with respiratory diseases primarily use inhalers and nebulizers for medication administration. The increase in incidences of respiratory diseases due to pollution and smoking habits and growing awareness about the need for early diagnosis and treatment of respiratory conditions has improved the need for inhalers & nebulizers. However, the high cost of advanced inhaler technologies, the complexity of medication adherence, and patient errors in using inhaler devices correctly limit the penetration of inhalers & nebulizers. Nevertheless, the development of smart inhalers integrated with digital capabilities for monitoring usage patterns and improving compliance and the emergence of customizable options to enhance user experience is expanding the scope of the inhalers & nebulizers market worldwide.

KEY MARKET STATISTICS
Base Year [2023] USD 9.30 billion
Estimated Year [2024] USD 11.45 billion
Forecast Year [2030] USD 38.63 billion
CAGR (%) 22.55%

Product: Wide availability of inhalers to overcome the respiratory disease burden

Inhalers are handheld devices that deliver medication as a mist or powder directly to the lungs. Dry powder inhalers (DPI) deliver medication as a dry, micronized powder. The patient inhales the powder deeply into the lungs through the device's mouthpiece. DPIs are often used for long-term maintenance therapy and are preferred by some patients due to their ease of use and portability. Metered dose inhalers are the commonly used inhalers and consist of a pressurized canister containing medication suspended in a propellant. When the canister is pressed down, it releases a fixed dose of the medicine in aerosol form, inhaled into the lungs. Nebulizers are medical devices used to administer medicine in the form of a mist inhaled into the lungs. Unlike inhalers, which deliver a single dose simultaneously, nebulizers can continuously deliver medication over several minutes. Jet or compressor nebulizers use compressed air to convert liquid drugs into fine mist. Jet nebulizers are commonly used in clinical and home settings but can be relatively noisy and less portable due to their size and the need for an air compressor. Mesh nebulizers are newer nebulizers that use fine mesh to produce medicinal mist. Mesh nebulizers are battery-operated and portable, making them ideal for patients who are mobile or need to administer medication while away from home. Ultrasonic nebulizers utilize high-frequency sound waves to generate vibrations that convert liquid medication into a fine mist. Ultrasonic nebulizers may not be suitable for all medications as the heat generated by the ultrasonic waves could potentially degrade certain compounds.

Indication: Increasing consumer preference for inhalers & nebulizers to treat asthma

Asthma is a chronic lung disease indicated by the narrowing of the airways, causing shortness of breath, wheezing, chest tightness, and coughing. The choice between inhalers and nebulizers for asthma patients often depends on factors such as age, severity of asthma, ease of use, and patient preference. Chronic obstructive pulmonary disease causes airflow blockage and breathing-related problems. Treatment usually involves long-acting bronchodilators, inhaled steroids, and other medications to manage symptoms. Asthma treatment tends to involve a broader array of short-acting medications for acute management and control of symptoms. In contrast, COPD treatments focus more on long-acting medicines to manage chronic symptoms.

Regional Insights

The Americas represents a highly developing and standardized inhalers & nebulizers market due to the high prevalence of respiratory diseases, supportive government approvals, and development of novel product portfolios. Customer purchasing behavior in the Americas is strongly influenced by technological advancements and the presence of major pharmaceutical vendors investing in innovative delivery systems. Asia-Pacific's investment in healthcare infrastructure and local pharmaceutical manufacturing fosters the growth of the inhalers & nebulizers market. A vast population and a rising incidence of respiratory conditions with an increasing trend in the use of generic drugs have expanded the scope of inhalers & nebulizers market in the Asia-Pacific. The European market is sophisticated, with stringent regulations and high penetration of advanced inhaler devices. The focus on patient compliance and ease of use drives the demand for smart and connected inhalers across the EMEA region. Africa is an emerging market with a high burden of respiratory diseases but has limited access to healthcare facilities. The increasing healthcare expenditure and desire for premium healthcare services and products are noticeable among the affluent customer segment across the EMEA region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Inhalers & Nebulizers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Inhalers & Nebulizers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Inhalers & Nebulizers Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AMIKO Digital Health, AptarGroup, Inc., Beurer GmbH, Beximco Pharmaceuticals Ltd., CHIESI Farmaceutici S.p.A., Cipla Limited, Dr Trust by Nureca Ltd., Drive DeVilbiss International, GF Health Products, Inc., GlaxoSmithKline PLC, H&T Presspart, ICONOVO AB, Koninklijke Philips N.V., Merck Group, Mundipharma GmbH, Narang Medical Limited, Novartis AG, Omron Corporation, PARI GmbH, Sensirion AG, Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., United Therapeutics Corporation, and Vectura Group Ltd..

Market Segmentation & Coverage

This research report categorizes the Inhalers & Nebulizers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Inhalers
      • Dry Powder Inhalers
      • Metered Dose Inhalers
    • Nebulizers
      • Jet Nebulizer
      • Mesh Nebulizer
      • Ultrasonic Nebulizer
  • Indication
    • Asthma
    • COPD
  • Distribution Mode
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Inhalers & Nebulizers Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Inhalers & Nebulizers Market?

3. What are the technology trends and regulatory frameworks in the Inhalers & Nebulizers Market?

4. What is the market share of the leading vendors in the Inhalers & Nebulizers Market?

5. Which modes and strategic moves are suitable for entering the Inhalers & Nebulizers Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Respiratory Diseases Globally
      • 5.1.1.2. Increasing Adoption of Nebulizers and Digitally-Improved Products
      • 5.1.1.3. Digital Health Partnerships Between Smart Inhaler Manufacturers and Software Companies
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Availability and High Costs Associated with the Development of Smart Inhalers
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in Smart Inhaler Devices and Systems
      • 5.1.3.2. Growing Investment and R&D by Market Players
    • 5.1.4. Challenges
      • 5.1.4.1. Practical Problems Associated with Inhalers & Nebulizers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Wide availability of inhalers to overcome the respiratory disease burden
    • 5.2.2. Indication: Increasing consumer preference for inhalers & nebulizers to treat asthma
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization
    • 5.9.1. Patent Analysis & Trend

6. Inhalers & Nebulizers Market, by Product

  • 6.1. Introduction
  • 6.2. Inhalers
  • 6.3. Nebulizers

7. Inhalers & Nebulizers Market, by Indication

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. COPD

8. Inhalers & Nebulizers Market, by Distribution Mode

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Inhalers & Nebulizers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Inhalers & Nebulizers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Inhalers & Nebulizers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. 1nhaler Raises USD 2.5 Million for Sustainable Single-Use Inhaler
    • 12.3.2. Lupin Unit Introduces Inhaler for Asthma Patients in Germany
    • 12.3.3. Synergy Life Science Releases Nebi, a Portable Nebulizer

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. INHALERS & NEBULIZERS MARKET RESEARCH PROCESS
  • FIGURE 2. INHALERS & NEBULIZERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INHALERS & NEBULIZERS MARKET DYNAMICS
  • FIGURE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INHALERS & NEBULIZERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. INHALERS & NEBULIZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INHALERS & NEBULIZERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY JET NEBULIZER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ASTHMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COPD, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COPD, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 120. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 127. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 130. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 137. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 140. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 147. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 150. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 157. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 160. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 167. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 170. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 180. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 187. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 190. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 200. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 207. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 208. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 209. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 210. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 217. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 220. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 227. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 230. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 249. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 252. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 259. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 262. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 269. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 272. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 279. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 280. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 281. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 282. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 289. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 292. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 293. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 294. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 299. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 302. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 303. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 304. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 309. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 310. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 311. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 312. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 313. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 314. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 322. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 324. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 329. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 330. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 331. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 332. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 333. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 334. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 339. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 340. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 341. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 342. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 343. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 344. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY INHALERS & NEBULIZER